SCOPUS BIOPHARMA INC.

(SCPS)
  Rapporto
Tempo differito Nasdaq  -  21:59 19/08/2022
0.3901 USD   +2.39%
16/08Scopus BioPharma Inc. riporta i risultati degli utili per il secondo trimestre e i sei mesi conclusi il 30 giugno 2022
CI
20/05Scopus BioPharma Inc. annuncia le dimissioni di Paul Hopper dal Consiglio di Amministrazione
CI
19/05Scopus BioPharma Inc. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2022
CI
RiassuntoQuotazioniGraficiNotizieRatingCalendarioSocietąFinanzaDerivati 
RiassuntoTutte le notizieRaccomandazione analistiAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settore
Notizie in altre lingue su SCOPUS BIOPHARMA INC.
16/08SCOPUS BIOPHARMA INC. Management's Discussion and Analysis of Financial Condition and ..
16/08Scopus BioPharma Inc. Reports Earnings Results for the Second Quarter and Six Months En..
15/07SCOPUS BIOPHARMA INC.: Notice of Delisting or Failure to Satisfy a Continued Listing Rule..
11/07Top Premarket Decliners
27/05SCOPUS BIOPHARMA INC.: Notice of Delisting or Failure to Satisfy a Continued Listing Rule..
20/05SCOPUS BIOPHARMA: Sydney, May 19, 2022 - Form 8-K
20/05SCOPUS BIOPHARMA INC.: Change in Directors or Principal Officers, Financial Statements an..
20/05Scopus BioPharma Inc. Announces Resignation of Paul Hopper from Board of Directors
19/05SCOPUS BIOPHARMA INC. Management's Discussion and Analysis of Financial Condition and ..
19/05Scopus BioPharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 20..
13/05SCOPUS BIOPHARMA INC.: Change in Directors or Principal Officers, Financial Statements an..
13/05Scopus Biopharma Inc. Announces Resignation of Ashish Sanghrajka from the Board of Dire..
05/05Scopus BioPharma Announces Biotechnology Industry Leader Rejoins Board of Directors
05/05Scopus BioPharma Announces Biotechnology Industry Leader Rejoins Board of Directors
05/05Scopus BioPharma Inc. Appoints Raphael Hofstein to its Board of Directors
04/05SCOPUS BIOPHARMA INC.: Change in Directors or Principal Officers (form 8-K)
30/04SCOPUS BIOPHARMA: Attn. Joshua R. Lamstein - Form 8-K
29/04SCOPUS BIOPHARMA INC.: Change in Directors or Principal Officers, Financial Statements an..
29/04Scopus Biopharma Inc. Announces Board Resignations
15/04SCOPUS BIOPHARMA INC. Management's Discussion and Analysis of Financial Condition and ..
15/04Scopus BioPharma Inc. Reports Earnings Results for the Full Year Ended December 31, 202..
08/04SCOPUS BIOPHARMA INC.: Notice of Delisting or Failure to Satisfy a Continued Listing Rule..
24/03SCOPUS BIOPHARMA INC.: Notice of Delisting or Failure to Satisfy a Continued Listing Rule..
23/03SCOPUS BIOPHARMA INC.: Regulation FD Disclosure, Financial Statements and Exhibits (form ..
23/03Scopus BioPharma's Subsidiary — Duet BioTherapeutics — to Present at the 3r..
04/03SCOPUS BIOPHARMA INC.: Notice of Delisting or Failure to Satisfy a Continued Listing Rule..
26/02SCOPUS BIOPHARMA INC.: Changes in Registrant's Certifying Accountant (form 8-K)
18/02SCOPUS BIOPHARMA INC.: Changes in Registrant's Certifying Accountant, Financial Statement..
20/01SCOPUS BIOPHARMA INC.: Entry into a Material Definitive Agreement, Notice of Delisting or..
10/01Scopus BioPharma Provides Update Following Annual Meeting of Stockholders
10/01SCOPUS BIOPHARMA: Submission of Matters to a Vote of Security Holders - Form 8-K/A
10/01SCOPUS BIOPHARMA INC. Submission of Matters to a Vote of Security Holders, Other Event..
10/01Scopus BioPharma Announces the Final Results
06/01Dr. morris c. laster wins proxy contest as stockholders elect his nominees to scopus bi..
06/01Scopus BioPharma Inc. Announces Board Appointments
2021SCOPUS BIOPHARMA INC.: Submission of Matters to a Vote of Security Holders (form 8-K)
2021Declaration of Preliminary Voting Results by Scopus BioPharma
2021Scopus BioPharma Issues Open Letter to Stockholders Detailing Morris Laster's Campaign ..
2021Scopus BioPharma Sends Letter to its Shareholders
2021Scopus BioPharma Sends Letter to its Shareholders
2021Scopus BioPharma Sends Letter Urging Stockholders to Vote “FOR ALL” of the ..
2021Dr. Morris C. Laster Issues An Open Letter To Scopus BioPharma Inc. Stockholders In Con..
2021Morris C. Laster Solicits Proxies from Shareholders of Scopus BioPharma
2021SCOPUS BIOPHARMA: Announces $9.75 Million Private Placement Priced At-The-Market - Form 8..
2021SCOPUS BIOPHARMA INC.: Entry into a Material Definitive Agreement, Unregistered Sale of E..
2021Scopus BioPharma Solicits Proxies from the Shareholders
2021Scopus BioPharma Inc. announced that it has received $9.75 million in funding
2021Scopus BioPharma Announces $9.75 Million Private Placement Priced At-The-Market
2021Scopus BioPharma Inc. announced that it expects to receive $9.75 million in funding
2021SCOPUS BIOPHARMA INC. Management's Discussion and Analysis of Financial Condition and ..
2021Scopus BioPharma Inc. Reports Earnings Results for the Third Quarter and Nine Months En..
2021Scopus BioPharma Announces Adjournment of Annual Meeting of Stockholders
2021Scopus BioPharma Adjourns its Annual General Meeting of Shareholders
2021SCOPUS BIOPHARMA: Announces Adjournment of Annual Meeting of Stockholders
2021Morris C. Laster Solicits Proxies from Shareholders of Scopus BioPharma
2021Scopus BioPharma to Present at the LD Micro Main Event
2021SCOPUS BIOPHARMA: to Present at the LD Micro Main Event
2021SCOPUS BIOPHARMA: Retaining Counsel to Investigate Unusual Market Activity
2021SCOPUS BIOPHARMA: to Present at MicroCap Rodeo's Fall Harvest Best Ideas Conference
2021SCOPUS BIOPHARMA: INDEMNIFICATION AGREEMENT (Form 8-K)
2021SCOPUS BIOPHARMA INC.: Entry into a Material Definitive Agreement, Other Events, Financia..
2021SCOPUS BIOPHARMA: Subsidiary — Duet Therapeutics — Announces Release of Precl..
2021SCOPUS BIOPHARMA: Subsidiary — Duet Therapeutics — Announces Release of Precl..
2021SCOPUS BIOPHARMA: Subsidiary Duet Therapeutics Set to Release Scientific Data During the ..
2021Scopus BioPharma's Subsidiary — Duet Therapeutics — Set to Release Scientif..
2021Scopus BioPharma Provides Information to Shareholders
2021SCOPUS BIOPHARMA: to Adjourn 2021 Annual Meeting of Stockholders
2021SCOPUS BIOPHARMA: to Present at the Benzinga Healthcare Small Cap Conference
2021SCOPUS BIOPHARMA: Subsidiary — Duet Therapeutics — to Present at the 17th Ann..
2021SCOPUS BIOPHARMA: Subsidiary — Duet Therapeutics — to Present at the 17th Ann..
2021SCOPUS BIOPHARMA: China National Intellectual Property Administration Grants New Patent C..
2021DR. MORRIS C. LASTER: Files Preliminary Proxy Statement Nominating Two Highly-Qualified I..
2021SCOPUS BIOPHARMA INC.(NASDAQGM: SCPS) added to S&P TMI Index
2021SCOPUS BIOPHARMA: Subsidiary — Duet Therapeutics — Announces Appointments of ..
2021SCOPUS BIOPHARMA INC.: Regulation FD Disclosure, Financial Statements and Exhibits (form ..
1  2  3Succ.